Skip to main content

Home/ health information/ Group items matching "Glenmark-Pharma-US-recall" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
pharmacybiz

Cipla & Glenmark: FDA Recalls Impacting UK Market - 0 views

www.pharmacy.biz/...et-due-to-manufacturing-issues

Cipla-recall-US-market Glenmark-Pharma-US-recall Cipla-manufacturing-concerns-USFDA Cipla-Indore-SEZ-plant-recall USFDA-Class-II-recall-Glenmark-Pharma

shared by pharmacybiz on 13 May 24 - No Cached
  • pharmacybiz on 13 May 24
     
    Two Indian pharmaceutical companies, Cipla and Glenmark, are pulling back certain products from the American market due to manufacturing concerns, according to the US Food and Drug Administration (USFDA). A New Jersey-based subsidiary of Cipla is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution due to "short fill", news agency PTI reported, quoting the latest Enforcement Report issued by the US health regulator. Produced at the company's Indore SEZ plant, this medication is used to manage symptoms associated with lung diseases, such as asthma, chronic bronchitis and emphysema. Cipla USA decided to recall the affected lot following complaints of less fill volume in respule and few drops of liquid observed in the intact pouch, the USFDA said, adding that the drug maker initiated the Class II recall in the US market on March 26 this year.
1 - 1 of 1
Showing 20▼ items per page